Applied DNA Sciences has formed a subsidiary named Applied DNA Clinical Labs, which will develop tests for the detection of Covid-19. The newly formed subsidiary will also explore development of test for detection of invasive Circulating Tumor Cells (iCTCs). The company plans to increase its market reach with the development of value-added services in addition to the portfolio of diagnostic assays.
